This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zelent, A. Articles by Waxman, S. Search for Related Content PubMed PubMed Citation Articles by Zelent, A. Articles by Waxman, S.

Molecular Target-Based Treatment of Human Cancer: Summary of the 10th International Conference on Differentiation Therapy

¹ Section of Haematological Oncology, Institute of Cancer Research, London, United Kingdom; ² Shanghai Institute of Hematology, Rui-Jin Hospital, Shanghai, China; ³ University of Texas M. D. Anderson Cancer Center, Houston, Texas; ⁴ University of Freiburg Medical Center, Freiburg, Germany; ⁵ Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; ⁶ Aichi Cancer Center Hospital, Nagoya, Japan; ⁷ Institut d'hematologie, Hôpital St. Louis, Paris, France; and ⁸ Department of Medicine, Mount Sinai School of Medicine, New York, New York

Requests for reprints: Samuel Waxman, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029. Tel: 212-241-7995; Fax: 212-996-5787; E-mail: samuel.waxman{at}mssm.edu.

The 10th International Conference on Differentiation Therapy was held between April 29 and May 3, 2004, in Shanghai, China. In the tradition of previous conferences from this series, which have been held biannually since the first meeting organized 20 years ago by Samuel Waxman and Giovanni Rossi in Sardinia, the organizers of the 10th International Conference on Differentiation Therapy aimed to gather basic and clinical cancer investigators in a setting of plenary sessions, workshops, and poster presentations to maximize the effective exchange of information and foster the establishment of collaborative interactions. Approximately 300 scientists attended the meeting with a mission to discuss targeted approaches to cancer treatment, which stem from our understanding of basic biological processes and the mechanisms of their deregulation during tumorigenesis.

This article has been cited by other articles:

				L. Delva, A. Zelent, T. Naoe, P. Fenaux, S. Waxman, L. Degos, and C. Chomienne Meeting Report: The 11th International Conference on Differentiation Therapy and Innovative Therapeutics in Oncology Cancer Res., November 15, 2007; 67(22): 10635 - 10637. [Full Text] [PDF]

				H. Shi, J. Guo, D. J. Duff, F. Rahmatpanah, R. Chitima-Matsiga, M. Al-Kuhlani, K. H. Taylor, O. Sjahputera, M. Andreski, J. E. Wooldridge, et al. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma Carcinogenesis, January 1, 2007; 28(1): 60 - 70. [Abstract] [Full Text] [PDF]